Antibiotic combinations in experimental infections in animals
Reviews of Infectious Diseases
|March 1, 1982
Summary
Combination antibiotic therapy is most effective for infections where host defenses are limited, particularly when the combination rapidly kills microbes. This review examines synergy methods for evaluating antibiotic efficacy in experimental infections and human applications.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Experimental infections in animal models provide insights into antimicrobial therapy.
- Host defenses are often compromised in severe infections like endocarditis and meningitis.
- Evaluating combination antibiotic therapy is crucial for treating infections where host immunity is insufficient.
Purpose of the Study:
- To review experimental studies on combination antibiotic therapy for infections with limited host defenses.
- To assess the effectiveness of antibiotic combinations based on microbial killing speed and synergy.
- To provide recommendations for applying synergy testing methods to human infections.
Main Methods:
- Review of experimental infection studies focusing on combination antibiotic therapy.
- Analysis of microbial killing rates and synergistic effects of antibiotic combinations.
- Examination of in vitro and in vivo methods for demonstrating antimicrobial synergy.
Main Results:
- Antibiotic combinations demonstrating rapid microbial killing were more effective in experimental infections.
- Enhanced microbial killing, rather than just synergy, correlated with treatment success.
- Certain synergy testing methods showed greater relevance for predicting clinical outcomes.
Conclusions:
- Rapid microbial killing by antibiotic combinations is a key factor for treating infections with compromised host defenses.
- Synergy testing methods should be carefully selected and validated for their predictive value in human infections.
- Further research is needed to optimize the application of experimental findings to clinical practice.
More Related Videos
Related Concept Videos
Antibiotic Selection
Overview
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


